|
| Cytokine storm during chemotherapy: a new companion diagnostic emerges? |
|
https://doi.org/10.18632/oncotarget.27442
Panagiota S. Filippou, George S. Karagiannis
|
| 213-215 |
|
| A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib |
|
https://doi.org/10.18632/oncotarget.27400
Wayne D. Blosser, Jack A. Dempsey, Ann M. McNulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Wang Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean Buchanan, Karsten Boehnke, Chunping Yu, Xin Tian You, Richard P. Beckmann, Wenjuan Wu, Samuel C. McNeely, Aimee Bence Lin, Ricardo Martinez
|
| 216-236 |
|
| Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes |
|
https://doi.org/10.18632/oncotarget.27428
Franziska Büscheck, Christoph Fraune, Ronald Simon, Martina Kluth, Claudia Hube-Magg, Christina Möller-Koop, Imren Sarper, Kathrin Ketterer, Tjark Henke, Christian Eichelberg, Roland Dahlem, Waldemar Wilczak, Guido Sauter, Margit Fisch, Till Eichenauer, Michael Rink
|
| 237-249 |
|
| TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC |
|
https://doi.org/10.18632/oncotarget.27430
Julia Roeper, Markus Falk, Athena Chalaris-Rißmann, Anne C. Lueers, Hayat Ramdani, Katrin Wedeken, Ursula Stropiep, Linda Diehl, Markus Tiemann, Lukas C. Heukamp, Fabian Otto-Sobotka, Frank Griesinger
|
| 250-264 |
|
| Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR |
|
https://doi.org/10.18632/oncotarget.27435
Hengyu Lu, Chen Liu, Hung Huynh, Thi Bich Uyen Le, Matthew J. LaMarche, Morvarid Mohseni, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Huai-Xiang Hao
|
| 265-281 |
|
| The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis |
|
https://doi.org/10.18632/oncotarget.27436
Ryan M. Carey, Karthik Rajasekaran, Tyler Seckar, Xiang Lin, Zhi Wei, Charles C.L. Tong, Viran J. Ranasinghe, Jason G. Newman, Bert W. O'Malley Jr., Gregory S. Weinstein, Michael D. Feldman, Erle S. Robertson
|
| 282-293 |
|
| Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy |
|
https://doi.org/10.18632/oncotarget.27323
Dmitry M. Ponomarenko, Vladimir L. Gabai, Albert A. Sufianov, Sergey I. Kolesnikov, Alexander M. Shneider
|
| 294-299 |
|
| Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells |
|
https://doi.org/10.18632/oncotarget.27373
Hao Yang, Hui Hui, Qian Wang, Hui Li, Kai Zhao, Yuxin Zhou, Yu Zhu, Xiaotang Wang, Qidong You, Qinglong Guo, Na Lu
|
| 300-301 |
|
| Correction: Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation |
|
https://doi.org/10.18632/oncotarget.27441
Jie Zhang, Pengxing He, Yong Xi, Meiyu Geng, Yi Chen, Jian Ding
|
| 302-303 |
|
| Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation |
|
https://doi.org/10.18632/oncotarget.27450
Ying Yan, Ashley L. Hein, Asserewou Etekpo, Katrina M. Burchett, Chi Lin, Charles A. Enke, Surinder K. Batra, Kenneth H. Cowan, Michel M. Ouellette
|
| 304-304 |
|
| Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors |
|
https://doi.org/10.18632/oncotarget.27402
Amanda M. Smith, Christine R.C. Zhang, Alexandre S. Cristino, John P. Grady, J. Lynn Fink, Andrew S. Moore
|
| 305-305 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
